Hainan Poly Pharm Co Ltd (300630) - Total Liabilities

Latest as of September 2024: CN¥3.45 Billion CNY ≈ $504.18 Million USD

Based on the latest financial reports, Hainan Poly Pharm Co Ltd (300630) has total liabilities worth CN¥3.45 Billion CNY (≈ $504.18 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 300630 cash generation efficiency to assess how effectively this company generates cash.

Hainan Poly Pharm Co Ltd - Total Liabilities Trend (2016–2023)

This chart illustrates how Hainan Poly Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Hainan Poly Pharm Co Ltd's assets to evaluate the company's liquid asset resilience ratio.

Hainan Poly Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hainan Poly Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
WithTech Inc. KQ:348350	Korea	₩21.51 Billion
SAURASHTRA CEM B ORD (BSE) NSE:SAURASHCEM	India	Rs6.24 Billion
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS IS:LKMNH	Turkey	TL2.76 Billion
Tridomain Performance Materials PT JK:TDPM	Indonesia	Rp128.03 Million
Hindustan Composites Limited NSE:HINDCOMPOS	India	Rs1.22 Billion
Lida Holdings Ltd TW:4552	Taiwan	NT$1.74 Billion
ANDRADA MINING LTD. F:9IA	Germany	€43.56 Million

Liability Composition Analysis (2016–2023)

This chart breaks down Hainan Poly Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Hainan Poly Pharm Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.56	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hainan Poly Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hainan Poly Pharm Co Ltd (2016–2023)

The table below shows the annual total liabilities of Hainan Poly Pharm Co Ltd from 2016 to 2023.

Year	Total Liabilities	Change
2023-12-31	CN¥3.38 Billion ≈ $494.67 Million	+7.10%
2022-12-31	CN¥3.16 Billion ≈ $461.90 Million	+48.86%
2021-12-31	CN¥2.12 Billion ≈ $310.29 Million	+108.54%
2020-12-31	CN¥1.02 Billion ≈ $148.80 Million	+77.04%
2019-12-31	CN¥574.37 Million ≈ $84.05 Million	+154.48%
2018-12-31	CN¥225.70 Million ≈ $33.03 Million	+47.37%
2017-12-31	CN¥153.16 Million ≈ $22.41 Million	+15.50%
2016-12-31	CN¥132.60 Million ≈ $19.40 Million	--

About Hainan Poly Pharm Co Ltd

SHE:300630 China Drug Manufacturers - Specialty & Generic

Market Cap

$73.10 Million

CN¥499.57 Million CNY

Market Cap Rank

#20408 Global

#4699 in China

Share Price

CN¥0.89

Change (1 day)

+1.14%

52-Week Range

CN¥0.69 - CN¥0.90

All Time High

CN¥70.54